Caenorhabditis elegans neuron degeneration and mitochondrial suppression caused by selected environmental chemicals

International Journal of Biochemistry and Molecular Biology

Volumn 4, Issue 4, 2013, Pages 191-200

  Zhou, Shaoyu ^a,b   Wang, Zemin ^a   Klaunig, James E ^a  

^a INDIANA UNIVERSITY   (United States)

^b Primetox Technologies   (China)

Author keywords

C. elegans; Caenorhabditis elegans; Environmental chemicals; Mitochondrial suppression; Neuron degeneration

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; BIOGENESIS; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DNA SYNTHESIS; DOPAMINERGIC NERVE CELL; GENE CONTROL; MITOCHONDRIAL GENOME; MITOCHONDRION; MOLECULAR DYNAMICS; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SEQUENCE HOMOLOGY;

EID: 84890455125     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Thomas B and Beal MF. Molecular insights into Parkinson's disease. F1000 Med Rep 2011; 3: 7.
2. Dutheil F, Beaune P, Tzourio C, Loriot MA and Elbaz A. Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease. Arch Neurol 2010; 67: 739-45.
3. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP and Langston JW. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 2011; 119: 866-72.
4. Wang A, Costello S, Cockburn M, Zhang X, Bronstein J and Ritz B. Parkinson's disease risk from ambient exposure to pesticides. Eur J Epidemiol 2011; 26: 547-55.
5. Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, Hersh B, Schwartz J, Wright RO and Hu H. Association of cumulative lead exposure with Parkinson's disease. Environ Health Perspect 2010; 118: 1609-13.
6. Winklhofer KF and Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta 2010; 1802: 29-44.
7. Dimitriadi M and Hart AC. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans. Neurobiol Dis 2010; 40: 4-11.
8. Meyer JN, Leung MC, Rooney JP, Sendoel A, Hengartner MO, Kisby GE and Bess AS. Mitochondria as a target of environmental toxicants. Toxicol Sci 2013; 134: 1-17.
9. Wallace KB and Starkov AA, Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol 2000; 40: 353-88.
10. Wallace DC, Fan W and Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 2010; 5: 297-348.
11. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI and Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-7.
12. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-9.
13. Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z and Gasser T. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004; 74: 11-9.
14. Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, Grünblatt E, Moran LB, Mandel SA, Riederer P, Miller RM, Federoff HJ, Wüllner U, Papapetropoulos S, Youdim MB, Cantuti-Castelvetri I, Young AB, Vance JM, Davis RL, Hedreen JC, Adler CH, Beach TG, Graeber MB, Middleton FA, Rochet JC, Scherzer CR; Global PD Gene Expression (GPEX) Consortium. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med 2010; 2: 52ra73.
15. Okimoto R, Macfarlane JL, Clary DO, Wolstenholme DR. The mitochondrial genomes of two nematodes, Caenorhabditis elegans and Ascaris suum. Genetics 1992; 130: 471-98.
16. Leung MC, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, Meyer JN. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 2008; 106: 5-28.
17. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A and Greenamyre JT. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 2003; 23: 10756-64.
18. Settivari R, Levora J, Nass R. The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease. J Biol Chem 2009; 284: 35758-68.
19. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974; 77: 71-94.
20. Hope I. C. elegans: A Practical Approach. New York: Oxford University Press. 1999.
21. Jiang GC, Tidwell K, McLaughlin BA, Cai J, Gupta RC, Milatovic D, Nass R, Aschner M. Neurotoxic potential of depleted uranium effects in primary cortical neuron cultures and in Caenorhabditis elegans. Toxicol Sci 2007; 99: 553-65.
22. Nass R, Hall DH, Miller DM 3rd, Blakely RD. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2002; 99: 3264-9.
23. Novillo A, Won SJ, Li C, Callard IP. Changes in Nuclear Receptor and Vitellogenin Gene Expression in Response to Steroids and Heavy Metal in Caenorhabditis elegans. Integr Comp Biol 2005; 45: 61-71.
24. Hunter SE, Jung D, Di Giulio RT, Meyer JN. The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number. Methods 2010; 51: 444-51.
25. Caboni P, Sherer TB, Zhang N, Taylor G, Na HM, Greenamyre JT, Casida JE. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol 2004; 17: 1540-8.
26. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000; 3: 1301-6.
27. Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT, Shepherd S. Pesticide/environmental exposures and Parkinson's disease in East Texas. J Agromedicine 2008; 13: 37-48.
28. Betarbet R, Poisik O, Sherer TB, Greenamyre JT. Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease. Exp Neurol 2004; 187: 76-85.
29. Choi WS, Kruse SE, Palmiter RD and Xia Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci U S A 2008; 105: 15136-41.
30. Girish C and Muralidhara. Propensity of Selaginella delicatula aqueous extract to offset rotenone-induced oxidative dysfunctions and neurotoxicity in Drosophila melanogaster: Impli-cations for Parkinson's disease. Neurotoxicology 2012; 33: 444-56.
31. Parameshwaran K, Irwin MH, Steliou K, Pinkert CA. Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brain. Pharmacol Biochem Behav 2012; 101: 487-92.
32. Koopman WJ, Nijtmans LG, Dieteren CE, Roestenberg P, Valsecchi F, Smeitink JA and Willems PH. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal 2010; 12: 1431-70.
33. Bess AS, Crocker TL, Ryde IT and Meyer JN. Mitochondrial dynamics and autophagy aid in removal of persistent mitochondrial DNA damage in Caenorhabditis elegans. Nucleic Acids Res 2012; 40: 7916-31.
34. Leung MC, Rooney JP, Ryde IT, Bernal AJ, Bess AS, Crocker TL, Ji AQ and Meyer JN. Effects of early life exposure to ultraviolet C radiation on mitochondrial DNA content, transcription, ATP production, and oxygen consumption in developing Caenorhabditis elegans. BMC Pharmacol Toxicol 2013; 14: 9.
35. VanDuyn N, Settivari R, LeVora J, Zhou S, Unrine J and Nass R. The metal transporter SMF-3/DMT-1 mediates aluminum-induced dopamine neuron degeneration. J Neurochem 2013; 124: 147-57.